Beyond The Numbers: 4 Analysts Discuss NovoCure Stock
Beyond The Numbers: 4 Analysts Discuss NovoCure Stock
數字背後：4位分析師討論Novocure股票
During the last three months, 4 analysts shared their evaluations of NovoCure (NASDAQ:NVCR), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $22.0, along with a high estimate of $24.00 and a low estimate of $20.00. This current average has increased by 6.69% from the previous average price target of $20.62.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how financial experts...
登入免費觀看全文
登入/註冊